The need for an interdisciplinary network of investigations on HHT

Current Pharmaceutical Design

Volumn 12, Issue 10, 2006, Pages 1249-1251

  Pasculli, G ^a   Sallustio, G ^b   Sabba C ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Hereditary hemorrhagic telangiectasia; Multidisciplinary approach; Rendu Osler Weber; Systemic vascular dysplasia

Indexed keywords

ARTERIOVENOUS MALFORMATION; BLEEDING; BRAIN ABSCESS; CHROMOSOME 12; CHROMOSOME 9; EARLY DIAGNOSIS; GENE IDENTIFICATION; GENE MUTATION; GENE THERAPY; HEMATOTHORAX; HEMOPTYSIS; HUMAN; LUNG DISEASE; PREDICTION; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING; SHUNTING; STROKE; CLINICAL TRIAL; GENETICS; INTERDISCIPLINARY COMMUNICATION; PATHOPHYSIOLOGY; RESEARCH;

CLINICAL TRIALS; HUMANS; INTERDISCIPLINARY COMMUNICATION; RESEARCH; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 33744972119     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206776361327     Document Type: Review

References (18)

1. Mc Allister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, et al. Endoglin a TGF-β binding protein of endothelial cells is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994; 8: 345-51.
2. Johnson DW, Berg JN, Gallione CJ, Morondel I, Yoon SJ, Stenzel TT, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 1996; 13: 189-95.
3. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995, 333: 919-24.
4. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987; 82:989-97.
5. Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabba C. Health-Related Quality of Life in a rare disease: Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res 2004; 13: 1715-23.
6. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54: 714-29.
7. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, et al. Liver disease in patient with hereditary hemorrhagic telangiectasia. N Eng J Med 2000; 343: 931-36.
8. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Syndrome). Am J Med Gen 2000; 91: 66-7.
9. Dakeishi M, Shioya T, Wada Y, Shindo T, Osaka K, Manabe M, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002;19:140-48.
10. Kjeldsen AD, Vase P, Grew A. Hereditary hemorrhagic telangiectesia HHT. A population based study of prevalence and mortality in Danish HM patients. J Int Med 1999; 245: 31-41.
11. Wallace GM, Shovlin CL. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unliked to the know HHT genes endoglin and ALK-1. Thorax 2000; 55:685-90.
12. Lastella, P Sabba C Lenato GM Resta N Lattanzi W Gallitelli M et al. Endoglin gene mutations and polymorphism in Italian patients with Hereditary Hemorrhagic Telangiectasia. Clin Genet 2003; 63:536-40.
13. Sabbà C, Pasculli G, Cirulli A, Gallitelli M, Virgilio G, Guastamacchia E, et al. Rendu-Osler-Weber disease: experience with 56 patients. Annali Italiani di Medicina Interna 2002; 17: 173-179.
14. Kjeldsen AD, Oxhoij H, Anderson PE, Elle B, Jacobsen JP, Vase P. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999; 116:432-39.
15. Sabba C, Gallitelli M, Palasciano G. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in Hereditary Hemorrhagic Telangiectasia. N Eng J Med 2001; 345: 926.
16. Andreka P, Nadhazi Z, Muzes G, Szantho G, Vandor L, Konya L, Turner MS, Tulassay Z, Bishopric NH. Possible therapeutic targets in cardiac myocyte apoptosis. Curr Pharm Des 2004; 10(20): 2445-61.
17. Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacological and surgical therapy for primary postpartum hemorrhage. Curr Pharm Des 2005; 11(6): 759-73.
18. Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr Pharm Des 2005; 11(8): 1017-30.